Similar Search Results

Dangerous omissions : the consequences of ignoring decision uncertainty

Griffin, Susan C.; Claxton, Karl P.; Palmer, Stephen; … - In: Health economics 20 (2011) 2, pp. 212-224

Persistent link: https://www.econbiz.de/10008901988

Identifying research priorities : the value of information associated with repeat screening for age-related macular degeneration

Bojke, Laura; Claxton, Karl; Sculpher, Mark; Palmer, Stephen - In: Medical decision making : MDM ; official journal of the … 28 (2008) 1, pp. 33-43

Persistent link: https://www.econbiz.de/10003637624

Causes for concern : is NICE failing to uphold its responsibilities to all NHS patients?

Claxton, Karl; Sculpher, Mark; Palmer, Stephen; Culyer, … - In: Health economics 24 (2015) 1, pp. 1-7

Persistent link: https://www.econbiz.de/10011313247

Incorporating option values into the economic evaluation of health care technologies

Palmer, Stephen; Smith, Peter - In: Journal of health economics 19 (2000) 5, pp. 755-766

Persistent link: https://www.econbiz.de/10001503699

Negotiating shorter working hours

Evans, Alastair; Palmer, Stephen - 1985

Persistent link: https://www.econbiz.de/10000684681

Uncertainty, evidence and irrecoverable costs : Informing approval, pricing and research decisions for health technologies

Claxton, Karl; Palmer, Stephen; Longworth, Louise; … - 2011

Persistent link: https://www.econbiz.de/10009383300

A thermodynamic model for the global economy and its implications for macroeconomic theory and policy formulation

Palmer, Stephen J.; Alford, Harriet - In: Theoretical economics letters 8 (2018) 12, pp. 2741-2771

Persistent link: https://www.econbiz.de/10011951745

Cost-effectiveness analysis using data from multinational trials: the use of bivariate hierarchical modelling

Manca, Andrea; Lambert, Paul C.; Sculpher, Mark J.; … - 2007

Healthcare cost-effectiveness analysis (CEA) often uses individual patient data (IPD) from multinational randomised controlled trials. Although designed to account for between-patient sampling variability in the clinical and economic data, standard analytical approaches to CEA ignore the...

Persistent link: https://www.econbiz.de/10009474937

Decision modelling for health economic evaluation

Briggs, Andrew; Claxton, Karl; Sculpher, Mark J. - 2006

Persistent link: https://www.econbiz.de/10004868884

Do patient charge increases reduce the use of prescription medicines? : an economic perspective

Sculpher, Mark - In: Public money & management : integrating theory and … 11 (1991) 2, pp. 57-62

Persistent link: https://www.econbiz.de/10001107536